These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 8807104

  • 21. Haploidentical transplantation for acute lymphoblastic leukemia in childhood.
    Klingebiel T, Handgretinger R, Lang P, Bader P, Niethammer D.
    Blood Rev; 2004 Sep; 18(3):181-92. PubMed ID: 15183902
    [Abstract] [Full Text] [Related]

  • 22. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP.
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [Abstract] [Full Text] [Related]

  • 23. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
    Lee SH, Lee MH, Lee JH, Min YH, Lee KH, Cheong JW, Lee J, Park KW, Kang JH, Kim K, Kim WS, Jung CW, Choi SJ, Lee JH, Park K.
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073
    [Abstract] [Full Text] [Related]

  • 24. Unrelated peripheral blood stem cell transplantation with 'megadoses' of purified CD34+ cells in three children with refractory severe aplastic anemia.
    Schwinger W, Urban C, Lackner H, Kerbl R, Benesch M, Dornbusch HJ, Sovinz P, Schauenstein K, Schumm M, Handgretinger R.
    Bone Marrow Transplant; 2000 Mar; 25(5):513-7. PubMed ID: 10713628
    [Abstract] [Full Text] [Related]

  • 25. Autologous and allogeneic transplantation with peripheral blood CD34+ cells: a pediatric experience.
    Watanabe T, Kawano Y, Watanabe A, Takaue Y.
    Haematologica; 1999 Feb; 84(2):167-76. PubMed ID: 10091416
    [Abstract] [Full Text] [Related]

  • 26. Efficiency of human HLA-mismatched CD34+ cells from unrelated donors in establishing in vitro hematopoiesis in allogeneic long-term marrow cultures.
    La Russa VF, Kessler SW, Henson VA, Cutting M, Polsinelli T, Knight RD, Wright DG.
    Exp Hematol; 1996 Nov; 24(13):1475-83. PubMed ID: 8950230
    [Abstract] [Full Text] [Related]

  • 27. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I.
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [Abstract] [Full Text] [Related]

  • 28. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia.
    Kögler G, Nürnberger W, Fischer J, Niehues T, Somville T, Göbel U, Wernet P.
    Bone Marrow Transplant; 1999 Aug; 24(4):397-403. PubMed ID: 10467329
    [Abstract] [Full Text] [Related]

  • 29. Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors.
    Redei I, Langston AA, Lonial S, Cherry JK, Allen AJ, Hamilton E, Jones M, Bartlett VM, Waller EK.
    Bone Marrow Transplant; 2002 Sep; 30(6):335-40. PubMed ID: 12235516
    [Abstract] [Full Text] [Related]

  • 30. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M, André-Schmutz I, Hacein-Bey S, Schindler J, Vitetta H, Dupuis S, Quartier P, Chedeville G, Vilmer E, Casanova JL, Buffet R, Caillat-Zucman S, Radford I, Le Deist F, Fischer A.
    J Soc Biol; 2001 Sep; 195(1):65-8. PubMed ID: 11530503
    [Abstract] [Full Text] [Related]

  • 31. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
    Briones J, Urbano-Ispizua A, Lawler M, Rozman C, Gardiner N, Marín P, Salgado C, Féliz P, McCann S, Montserrat E.
    Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658
    [Abstract] [Full Text] [Related]

  • 32. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation.
    Lickliter JD, McGlave PB, DeFor TE, Miller JS, Ramsay NK, Verfaillie CM, Burns LJ, Wagner JE, Eastlund T, Dusenbery K, Weisdorf DJ.
    Bone Marrow Transplant; 2000 Oct; 26(7):723-8. PubMed ID: 11042652
    [Abstract] [Full Text] [Related]

  • 33. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
    Lee KH, Lee JH, Lee JH, Kim DY, Kim SH, Shin HJ, Lee YS, Kang YA, Seol M, Ryu SG.
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
    [Abstract] [Full Text] [Related]

  • 34. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD.
    Levine JE, Wiley J, Kletzel M, Yanik G, Hutchinson RJ, Koehler M, Neudorf S.
    Bone Marrow Transplant; 2000 Jan; 25(1):13-8. PubMed ID: 10654008
    [Abstract] [Full Text] [Related]

  • 35. [Application of FBC conditioning regimen in HLA haplotype peripheral blood stem cell transplantation].
    Wu B, Guo K, Song Z, Yan D, Yang Y, Xiao L.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):194-7. PubMed ID: 12133456
    [Abstract] [Full Text] [Related]

  • 36. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
    Lanfranchi A, Verardi R, Tettoni K, Neva A, Mazzolari E, Pennacchio M, Pasic S, Ugazio AG, Albertini A, Porta F.
    Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
    [Abstract] [Full Text] [Related]

  • 37. Allogeneic bone marrow and peripheral stem cell transplantation from a haplo-identical mother and CD34 positive selection for CML.
    Kato K, Kojima S, Kondo M, Inaba J, Matsuyama T.
    Bone Marrow Transplant; 1996 Aug; 18(2):449-52. PubMed ID: 8864462
    [Abstract] [Full Text] [Related]

  • 38. Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood.
    Kato S, Yabe H, Yasui M, Kawa K, Yoshida T, Watanabe A, Osugi Y, Horibe K, Kodera Y.
    Bone Marrow Transplant; 2000 Dec; 26(12):1281-90. PubMed ID: 11223967
    [Abstract] [Full Text] [Related]

  • 39. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y, Huang X, Xu L, Liu D, Zhang Y, Ren H, Guo N, Lu D.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 10; 82(19):1306-9. PubMed ID: 12509932
    [Abstract] [Full Text] [Related]

  • 40. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y, Luo B, Sozen H, Kalscheuer H, Blazar BR, Sutherland DE, Hering BJ, Guo Z.
    Transplantation; 2003 Jul 15; 76(1):216-24. PubMed ID: 12865813
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.